In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Bristol-Myers Squibb Co. (NYSE: BMY) closed at $44.94 in the last session, up 0.45% from day before closing price of $44.74. In other words, the price has increased by $0.45 from its previous closing price. On the day, 8.68 million shares were traded. BMY stock price reached its highest trading level at $44.97 during the session, while it also had its lowest trading level at $44.3.
Ratios:
We take a closer look at BMY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.28. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.11. In the meantime, Its Debt-to-Equity ratio is 3.48 whereas as Long-Term Debt/Eq ratio is at 3.10.
On February 06, 2024, Redburn Atlantic Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $77 to $54.
BofA Securities Downgraded its Buy to Neutral on January 03, 2024, whereas the target price for the stock was revised from $68 to $60.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 05 ’23 when BOERNER CHRISTOPHER S. bought 2,000 shares for $49.78 per share. The transaction valued at 99,560 led to the insider holds 82,672 shares of the business.
BOERNER CHRISTOPHER S. bought 3,071 shares of BMY for $150,049 on Nov 28 ’23. The Chief Executive Officer now owns 79,384 shares after completing the transaction at $48.86 per share. On Nov 20 ’23, another insider, Samuels Theodore R. II, who serves as the Director of the company, bought 8,500 shares for $49.81 each. As a result, the insider paid 423,385 and bolstered with 35,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 91097874432 and an Enterprise Value of 138942873600. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.00 while its Price-to-Book (P/B) ratio in mrq is 5.52. Its current Enterprise Value per Revenue stands at 3.051 whereas that against EBITDA is 7.646.
Stock Price History:
The Beta on a monthly basis for BMY is 0.45, which has changed by -0.3407657 over the last 52 weeks, in comparison to a change of 0.26265144 over the same period for the S&P500. Over the past 52 weeks, BMY has reached a high of $69.10, while it has fallen to a 52-week low of $43.33. The 50-Day Moving Average of the stock is -9.70%, while the 200-Day Moving Average is calculated to be -15.61%.
Shares Statistics:
According to the various share statistics, BMY traded on average about 15.42M shares per day over the past 3-months and 12700180 shares per day over the past 10 days. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 79.90% stake in the company. Shares short for BMY as of 1714435200 were 28024749 with a Short Ratio of 1.82, compared to 1711584000 on 35116032. Therefore, it implies a Short% of Shares Outstanding of 28024749 and a Short% of Float of 1.38.
Dividends & Splits
The forward annual dividend rate for BMY is 2.34, which was 2.34 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.052302185The stock’s 5-year Average Dividend Yield is 3.25. The current Payout Ratio is 59.82% for BMY, which recently paid a dividend on 2024-04-04 with an ex-dividend date of 1712188800. Stock splits for the company last occurred on 2001-08-07 when the company split stock in a 1000000:951777 ratio.
Earnings Estimates
The firm’s stock currently is rated by 16.0 analysts. On average, analysts expect EPS of $1.7 for the current quarter, with a high estimate of $2.05 and a low estimate of $1.55, while EPS last year was $1.75. The consensus estimate for the next quarter is $1.64, with high estimates of $1.72 and low estimates of $1.56.
Analysts are recommending an EPS of between $0.67 and $0.36 for the fiscal current year, implying an average EPS of $0.56. EPS for the following year is $6.92, with 22.0 analysts recommending between $7.69 and $6.27.
Revenue Estimates
For the next quarter, 15 analysts are estimating revenue of $11.19B. There is a high estimate of $11.52B for the next quarter, whereas the lowest estimate is $10.97B.
A total of 23 analysts have provided revenue estimates for BMY’s current fiscal year. The highest revenue estimate was $46.88B, while the lowest revenue estimate was $45.28B, resulting in an average revenue estimate of $46.1B. In the same quarter a year ago, actual revenue was $42.04BBased on 23 analysts’ estimates, the company’s revenue will be $46.12B in the next fiscal year. The high estimate is $47.77B and the low estimate is $42.68B.
